新冠疫情与信使核糖核酸疫苗——新方法的首次大规模试验 - Suppr

Suppr

超能文献

COVID-19 and mRNA Vaccines-First Large Test for a New Approach.

作者信息

Abbasi Jennifer

出版信息

JAMA. 2020 Sep 22;324(12):1125-1127. doi: 10.1001/jama.2020.16866.

DOI:10.1001/jama.2020.16866

PMID:32880613

Abstract

摘要

相似文献

COVID-19 and mRNA Vaccines-First Large Test for a New Approach.

JAMA. 2020 Sep 22;324(12):1125-1127. doi: 10.1001/jama.2020.16866.

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.

Virol Sin. 2020 Jun;35(3):259-262. doi: 10.1007/s12250-020-00243-0. Epub 2020 Jun 10.

Developing a SARS-CoV-2 Vaccine at Warp Speed.

JAMA. 2020 Aug 4;324(5):437-438. doi: 10.1001/jama.2020.12190.

Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.

Expert Rev Vaccines. 2020 Sep;19(9):781-784. doi: 10.1080/14760584.2020.1825946. Epub 2020 Oct 6.

Developing Covid-19 Vaccines at Pandemic Speed.

N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.

Amplifying RNA Vaccine Development.

N Engl J Med. 2020 Jun 18;382(25):2469-2471. doi: 10.1056/NEJMcibr2009737.

Audio Interview: Vaccinology and Covid-19.

N Engl J Med. 2020 Oct 15;383(16):e109. doi: 10.1056/NEJMe2031646.

[Not Available].

MMW Fortschr Med. 2020 Apr;162(7):56. doi: 10.1007/s15006-020-0398-7.

Vaccine designers take first shots at COVID-19.

Science. 2020 Apr 3;368(6486):14-16. doi: 10.1126/science.368.6486.14.

Sarah Gilbert: carving a path towards a COVID-19 vaccine.

Lancet. 2020 Apr 18;395(10232):1247. doi: 10.1016/S0140-6736(20)30796-0.

引用本文的文献

COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine.

Reports (MDPI). 2023 Sep 22;6(4):45. doi: 10.3390/reports6040045.

Reshaping the Treatment Landscape of a Galactose Metabolism Disorder.

J Inherit Metab Dis. 2025 Mar;48(2):e70013. doi: 10.1002/jimd.70013.

The COVID-19 Vaccine in Clinical Trials: Where Are We Now?

Infect Dis Immun. 2021 Apr 20;1(1):43-51. doi: 10.1097/ID9.0000000000000003. eCollection 2021 Apr.

Benefits and Pitfalls of Debunking Interventions to Counter mRNA Vaccination Misinformation During the COVID-19 Pandemic.

Sci Commun. 2022 Oct;44(5):531-558. doi: 10.1177/10755470221129608.

A genomic platform for surveillance and antigen discovery in Plasmodium spp. using long-read amplicon sequencing.

Cell Rep Methods. 2023 Sep 25;3(9):100574. doi: 10.1016/j.crmeth.2023.100574. Epub 2023 Aug 29.

Susceptibility of SARS-CoV2 infection in children.

Eur J Pediatr. 2023 Nov;182(11):4851-4857. doi: 10.1007/s00431-023-05184-w. Epub 2023 Sep 13.

COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review.

Int J Mol Sci. 2023 May 25;24(11):9231. doi: 10.3390/ijms24119231.

Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan.

Vaccines (Basel). 2023 Jan 11;11(1):157. doi: 10.3390/vaccines11010157.

Efficacy and safety of COVID-19 vaccines.

Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.

Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in medical personnel.

Postepy Dermatol Alergol. 2022 Oct;39(5):913-922. doi: 10.5114/ada.2022.120884. Epub 2022 Nov 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

COVID-19 and mRNA Vaccines-First Large Test for a New Approach.

JAMA. 2020 Sep 22;324(12):1125-1127. doi: 10.1001/jama.2020.16866.

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.

Virol Sin. 2020 Jun;35(3):259-262. doi: 10.1007/s12250-020-00243-0. Epub 2020 Jun 10.

Developing a SARS-CoV-2 Vaccine at Warp Speed.

JAMA. 2020 Aug 4;324(5):437-438. doi: 10.1001/jama.2020.12190.

Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.

Expert Rev Vaccines. 2020 Sep;19(9):781-784. doi: 10.1080/14760584.2020.1825946. Epub 2020 Oct 6.

Developing Covid-19 Vaccines at Pandemic Speed.

N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.

Amplifying RNA Vaccine Development.

N Engl J Med. 2020 Jun 18;382(25):2469-2471. doi: 10.1056/NEJMcibr2009737.

Audio Interview: Vaccinology and Covid-19.

N Engl J Med. 2020 Oct 15;383(16):e109. doi: 10.1056/NEJMe2031646.

[Not Available].

MMW Fortschr Med. 2020 Apr;162(7):56. doi: 10.1007/s15006-020-0398-7.

Vaccine designers take first shots at COVID-19.

Science. 2020 Apr 3;368(6486):14-16. doi: 10.1126/science.368.6486.14.

Sarah Gilbert: carving a path towards a COVID-19 vaccine.

Lancet. 2020 Apr 18;395(10232):1247. doi: 10.1016/S0140-6736(20)30796-0.

引用本文的文献

COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine.

Reports (MDPI). 2023 Sep 22;6(4):45. doi: 10.3390/reports6040045.

Reshaping the Treatment Landscape of a Galactose Metabolism Disorder.

J Inherit Metab Dis. 2025 Mar;48(2):e70013. doi: 10.1002/jimd.70013.

The COVID-19 Vaccine in Clinical Trials: Where Are We Now?

Infect Dis Immun. 2021 Apr 20;1(1):43-51. doi: 10.1097/ID9.0000000000000003. eCollection 2021 Apr.

Benefits and Pitfalls of Debunking Interventions to Counter mRNA Vaccination Misinformation During the COVID-19 Pandemic.

Sci Commun. 2022 Oct;44(5):531-558. doi: 10.1177/10755470221129608.

A genomic platform for surveillance and antigen discovery in Plasmodium spp. using long-read amplicon sequencing.

Cell Rep Methods. 2023 Sep 25;3(9):100574. doi: 10.1016/j.crmeth.2023.100574. Epub 2023 Aug 29.

Susceptibility of SARS-CoV2 infection in children.

Eur J Pediatr. 2023 Nov;182(11):4851-4857. doi: 10.1007/s00431-023-05184-w. Epub 2023 Sep 13.

COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review.

Int J Mol Sci. 2023 May 25;24(11):9231. doi: 10.3390/ijms24119231.

Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan.

Vaccines (Basel). 2023 Jan 11;11(1):157. doi: 10.3390/vaccines11010157.

Efficacy and safety of COVID-19 vaccines.

Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477.

Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in medical personnel.

Postepy Dermatol Alergol. 2022 Oct;39(5):913-922. doi: 10.5114/ada.2022.120884. Epub 2022 Nov 9.